GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Pacific Edge Ltd (NZSE:PEB) » Definitions » Cash Flow from Financing

Pacific Edge (NZSE:PEB) Cash Flow from Financing : NZ$-1.23 Mil (TTM As of Sep. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Pacific Edge Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the six months ended in Sep. 2024, Pacific Edge paid NZ$0.00 Mil more to buy back shares than it received from issuing new shares. It received NZ$0.00 Mil from issuing more debt. It paid NZ$0.00 Mil more to buy back preferred shares than it received from issuing preferred shares. It received NZ$0.00 Mil from paying cash dividends to shareholders. It received NZ$0.00 Mil on other financial activities. In all, Pacific Edge spent NZ$0.00 Mil on financial activities for the six months ended in Sep. 2024.


Pacific Edge Cash Flow from Financing Historical Data

The historical data trend for Pacific Edge's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pacific Edge Cash Flow from Financing Chart

Pacific Edge Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.65 22.21 108.29 -1.37 -1.21

Pacific Edge Semi-Annual Data
Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.29 -1.08 -0.71 -0.50 -0.73

Pacific Edge Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Pacific Edge's Cash from Financing for the fiscal year that ended in Mar. 2024 is calculated as:

Pacific Edge's Cash from Financing for the quarter that ended in Sep. 2024 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NZ$-1.23 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pacific Edge  (NZSE:PEB) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Pacific Edge's issuance of stock for the six months ended in Sep. 2024 was NZ$0.00 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Pacific Edge's repurchase of stock for the six months ended in Sep. 2024 was NZ$0.00 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Pacific Edge's net issuance of debt for the six months ended in Sep. 2024 was NZ$0.00 Mil. Pacific Edge received NZ$0.00 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Pacific Edge's net issuance of preferred for the six months ended in Sep. 2024 was NZ$0.00 Mil. Pacific Edge paid NZ$0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Pacific Edge's cash flow for dividends for the six months ended in Sep. 2024 was NZ$0.00 Mil. Pacific Edge received NZ$0.00 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Pacific Edge's other financing for the six months ended in Sep. 2024 was NZ$0.00 Mil. Pacific Edge received NZ$0.00 Mil on other financial activities.


Pacific Edge Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Pacific Edge's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Pacific Edge Business Description

Traded in Other Exchanges
Address
87 St David Street, P.O. Box 56, Dunedin, STL, NZL, 9016
Pacific Edge Ltd is a NewZealand based company involved in developing and commercializing diagnostic and prognostic tools for the early detection and management of cancers. It manages and operates the laboratories used for the detection of bladder cancer. The company operates in two segments: Commercial, which includes sales, marketing, laboratory, and support operations to run the commercial businesses world wide; and Research, which is into research and development of diagnostic and prognostic products for human cancer. The commercial segment contributes to the majority of the revenue. Pacific Edge has a product in the marketplace called Cxbladder. Its geographical segments are the United States, New Zealand, and the Rest of the World.